Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Amylyx Pharmaceuticals, Inc. (AMLX) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $4.21B and a free-cash-flow yield of -4.0%. Over the most recent reported fiscal year, revenue declined 100.0%.